|
| 36632328 | Integrating real-world data to assess cardiac ablation device outcomes in a multicenter study using the OMOP common data model for regulatory decisions: implementation and evaluation. | JAMIA Open | 2023 |
| 37273820 | Race and Ethnic and Sex Differences in Rhythm Control Treatment of Incident Atrial Fibrillation. | Clinicoecon Outcomes Res | 2023 |
| 37235562 | Racial and Health Insurance Differences in Patient Outcomes After Surgical Treatment for Cauda Equina Syndrome: A United States Retrospective Hospital Claims Database Analysis. | Spine (Phila Pa 1976) | 2023 |
| 36697434 | Frequent and unpredictable changes in COVID-19 policies and restrictions reduce the accuracy of model forecasts. | Sci Rep | 2023 |
| 36738387 | Using real-world data from health systems to evaluate the safety and effectiveness of a catheter to treat ischemic ventricular tachycardia. | J Interv Card Electrophysiol | 2023 |
| 34896478 | Site-specific cancer risk following cobalt exposure via orthopedic implants or in occupational settings: A systematic review and meta-analysis. | Regul Toxicol Pharmacol | 2022 |
| 36545363 | Comparison of Clinical Outcomes of Gripping Surface Technology Staple Reloads versus Standard Staple Reloads Used with Manual Linear Surgical Staplers. | Med Devices (Auckl) | 2022 |
| 35909993 | Evaluation of intervertebral body implant performance using active surveillance of electronic health records. | BMJ Surg Interv Health Technol | 2022 |
| 35976649 | Safety and Effectiveness of a Catheter With Contact Force and 6-Hole Irrigation for Ablation of Persistent Atrial Fibrillation in Routine Clinical Practice. | JAMA Netw Open | 2022 |
| 32564221 | Trends in the diffusion of robotic surgery in prostate, uterus, and colorectal procedures: a retrospective population-based study. | J Robot Surg | 2021 |
| 33736712 | Monthly trend in mortality and length of stay among coronavirus disease 2019 (COVID-19) patients: Analysis of a nationwide multihospital US database. | Infect Control Hosp Epidemiol | 2021 |
| 33733059 | Improving visual communication of discriminative accuracy for predictive models: the probability threshold plot. | JAMIA Open | 2021 |
| 33531828 | Evolving Treatment Patterns for Hospitalized COVID-19 Patients in the United States in April 2020-July 2020. | Int J Gen Med | 2021 |
| 33530727 | Using machine learning to predict post-operative depth of focus after cataract surgery with implantation of Tecnis Symfony. | Eur J Ophthalmol | 2021 |
| 33662479 | Carcinogenic hazard assessment of cobalt-containing alloys in medical devices: Review of in vivo studies. | Regul Toxicol Pharmacol | 2021 |
| 35047806 | Feasibility of using real-world data in the evaluation of cardiac ablation catheters: a test-case of the National Evaluation System for Health Technology Coordinating Center. | BMJ Surg Interv Health Technol | 2021 |
| 34628108 | Challenges of evaluating and modelling vaccination in emerging infectious diseases. | Epidemics | 2021 |
| 34014860 | Comparative Safety of the TFN-ADVANCED Proximal Femoral Nailing System: Findings from a U.S. Health-Care Database. | J Bone Joint Surg Am | 2021 |
| 34313748 | Feasibility of capturing real-world data from health information technology systems at multiple centers to assess cardiac ablation device outcomes: A fit-for-purpose informatics analysis report. | J Am Med Inform Assoc | 2021 |
| 34229014 | Carcinogenic assessment of cobalt-containing alloys in medical devices or cobalt in occupational settings: A systematic review and meta-analysis of overall cancer risk from published epidemiologic studies. | Regul Toxicol Pharmacol | 2021 |
| 34256083 | An integrated benefit-risk assessment of cobalt-containing alloys used in medical devices: Implications for regulatory requirements in the European Union. | Regul Toxicol Pharmacol | 2021 |
| 32134325 | Intracardiac echocardiography use and outcomes after catheter ablation of ventricular tachycardia. | J Comp Eff Res | 2020 |
| 31868258 | Real-world outcomes of ventricular tachycardia catheter ablation with versus without intracardiac echocardiography. | J Cardiovasc Electrophysiol | 2020 |
| 33146901 | The utility of real-world evidence for benefit-risk assessment, communication, and evaluation of pharmaceuticals: Case studies. | Pharmacoepidemiol Drug Saf | 2020 |
| 32352038 | Aggregating multiple real-world data sources using a patient-centered health-data-sharing platform. | NPJ Digit Med | 2020 |
| 31020755 | Identifying and classifying opioid-related overdoses: A validation study. | Pharmacoepidemiol Drug Saf | 2019 |
| 31218780 | Using natural language processing of clinical text to enhance identification of opioid-related overdoses in electronic health records data. | Pharmacoepidemiol Drug Saf | 2019 |
| 31095831 | Development of an algorithm to identify inpatient opioid-related overdoses and oversedation using electronic data. | Pharmacoepidemiol Drug Saf | 2019 |
| 29978755 | Incidence of nonmedical use of OxyContin and other prescription opioid pain relievers before and after the introduction of OxyContin with abuse deterrent properties. | Postgrad Med | 2018 |
| 30130977 | Conditional power for assessing population interventions. | J Comp Eff Res | 2018 |
| 27373304 | ER/LA Opioid Analgesics REMS: Overview of Ongoing Assessments of Its Progress and Its Impact on Health Outcomes. | Pain Med | 2017 |
| 29308589 | Abuse of reformulated OxyContin: Updated findings from a sentinel surveillance sample of individuals assessed for substance use disorder. | J Opioid Manag | 2017 |
| 28829517 | Assessing the impact of the extended-release/long-acting opioid an-algesics risk evaluation and mitigation strategies on opioid prescrip-tion volume. | J Opioid Manag | 2017 |
| 28758289 | Changes in misuse and abuse of prescription opioids following implementation of Extended-Release and Long-Acting Opioid Analgesic Risk Evaluation and Mitigation Strategy. | Pharmacoepidemiol Drug Saf | 2017 |
| 27977317 | Disproportionality analysis of buprenorphine transdermal system and cardiac arrhythmia using FDA and WHO postmarketing reporting system data. | Postgrad Med | 2017 |
| 27922764 | Comparison of abuse, suspected suicidal intent, and fatalities related to the 7-day buprenorphine transdermal patch versus other opioid analgesics in the National Poison Data System. | Postgrad Med | 2017 |
| 28074520 | Assessing the accuracy of opioid overdose and poisoning codes in diagnostic information from electronic health records, claims data, and death records. | Pharmacoepidemiol Drug Saf | 2017 |
| 27372220 | Decreased diversion by doctor-shopping for a reformulated extended release oxycodone product (OxyContin). | Drug Alcohol Depend | 2016 |
| 27177423 | Protocol: changes in rates of opioid overdose and poisoning events in an integrated health system following the introduction of a formulation of OxyContin® with abuse-deterrent properties. | BMC Pharmacol Toxicol | 2016 |
| 27170195 | The effect of an abuse-deterrent opioid formulation (OxyContin) on opioid abuse-related outcomes in the postmarketing setting. | Clin Pharmacol Ther | 2016 |
| 27522950 | Adverse Event Reporting in Clinical Trials of Intravenous and Invasive Pain Treatments: An ACTTION Systematic Review. | J Pain | 2016 |
| 27520885 | Understanding opioid overdose characteristics involving prescription and illicit opioids: A mixed methods analysis. | Drug Alcohol Depend | 2016 |
| 25827064 | A retrospective cohort study of long-term immediate-release hydrocodone/acetaminophen use and acetaminophen dosing above the Food and Drug Administration recommended maximum daily limit among commercially insured individuals in the United States (2008-2013). | J Pain | 2015 |
| 26456379 | Benefit-Risk Assessment, Communication, and Evaluation (BRACE) throughout the life cycle of therapeutic products: overall perspective and role of the pharmacoepidemiologist. | Pharmacoepidemiol Drug Saf | 2015 |
| 24721614 | The impact of a reformulation of extended-release oxycodone designed to deter abuse in a sample of prescription opioid abusers. | Drug Alcohol Depend | 2014 |
| 24800858 | Monitoring of internet forums to evaluate reactions to the introduction of reformulated OxyContin to deter abuse. | J Med Internet Res | 2014 |
| 24916486 | Reductions in reported deaths following the introduction of extended-release oxycodone (OxyContin) with an abuse-deterrent formulation. | Pharmacoepidemiol Drug Saf | 2014 |
| 24913796 | Impact of vaccination on the epidemiology of varicella: 1995-2009. | Pediatrics | 2014 |
| 24510461 | Controlling controlled substances abuse and misuse by managed care payers: a new generation of risk management initiatives? | Pharmacoepidemiol Drug Saf | 2014 |
| 23127293 | Abuse rates and routes of administration of reformulated extended-release oxycodone: initial findings from a sentinel surveillance sample of individuals assessed for substance abuse treatment. | J Pain | 2013 |